OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In <i>Vitro</i> And In <i>Vivo</i> Glucose And Glutamine Usage
Khoa Pham(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Brad Poore(Johns Hopkins University), Micah J. Maxwell(Johns Hopkins University), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Barbara S. Slusher(Johns Hopkins University), Allison R. Hanaford(Johns Hopkins Medicine), Jesse Alt(Johns Hopkins University), Heather Sweeney(Johns Hopkins University), Rana Rais(Johns Hopkins University), Akhila Parthasarathy(Johns Hopkins University)
Cited by 1
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711